title: Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.
abstract: Endothelial cells have the ability to change their complement of cell surface proteins in response to inflammatory cytokines. We hypothesized that the expression of the coxsackievirus-adenovirus receptor (CAR), a viral receptor and putative cell-cell adhesion molecule, may be altered during the response of endothelial cells to inflammation. To test this hypothesis, we evaluated CAR protein and mRNA levels in human umbilical vein endothelial cells after they were exposed to tumor necrosis factor alpha, gamma interferon, or a combination of the two cytokines. Flow cytometric and Western blot analyses indicated that cytokine treatment led to a synergistic decrease in CAR protein expression. A Western blot analysis showed that CAR levels decreased to 16% +/- 4% or 1% +/- 4% of the CAR protein levels in untreated cells with either 24 or 48 h of cytokine treatment, respectively. Quantitative reverse transcription-PCR demonstrated that the combination treatment caused CAR mRNA levels to decrease to 21% +/- 12% or 5% +/- 3% of the levels in untreated cells after a 24- or 48-h cytokine treatment, respectively. Reduced CAR expression led to a decrease in adenovirus (Ad) binding of 80% +/- 3% (compared with untreated endothelial cells), with a subsequent decrease in Ad-mediated gene transfer that was dependent on the dose and duration of cytokine treatment but not on the dose of Ad. A similar decrease in CAR protein level and susceptibility to Ad infection was observed in human microvascular endothelial cells, while CAR expression on normal human bronchial epithelial cells or A549 lung epithelial cells was less affected by cytokine treatments. Taken together, the data demonstrate that inflammatory cytokines decrease CAR mRNA and protein expression with a concomitant decrease in Ad binding, reflecting the impact of cell physiology on the function of CAR and the potential effect of inflammation on the ability of Ad to transfer genes to endothelial cells.
authors.affiliation: Department of Genetic Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.
authors.forename: Theresa
authors.initials: T
authors.lastname: Vincent
authors.forename: Ralf F
authors.initials: RF
authors.lastname: Pettersson
authors.forename: Ronald G
authors.initials: RG
authors.lastname: Crystal
authors.forename: Philip L
authors.initials: PL
authors.lastname: Leopold
mesh_terms: D000256:Adenoviridae / Q000235:genetics / Q000502:physiology; D002478:Cells, Cultured; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D016207:Cytokines / Q000494:pharmacology*; D015536:Down-Regulation; D042783:Endothelial Cells / Q000737:chemistry*; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis; D011991:Receptors, Virus / Q000032:analysis* / Q000235:genetics / Q000502:physiology; D018523:Tropism; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: C568771:CLMP protein, human; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D016207:Cytokines; D012333:RNA, Messenger; D011991:Receptors, Virus; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma